SCHEMBL6819092

SCHEMBL6819092

O=Cc1ccc2cc(F)c(F)cc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.48
ALDH1A1 P00352 4/20 0.39
TERT O14746 2/20 0.38
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
KDM4E B2RXH2 3/20 0.35
NFKB1 P19838 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 2/20 0.35
PKM P14618 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 1/20 0.33
PDE10A Q9Y233 1/20 0.33
HPGD P15428 1/20 0.33
PTPN1 P18031 1/20 0.31
S1PR4 O95977 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7806544 0.87 CCR1 (0.44) CCR1ALDH1A1TERTNPC1RAB9A
SCHEMBL13739830 0.81 CCR1 (0.39) CCR1ALDH1A1RAB9ALMNAL3MBTL1
SCHEMBL4050836 0.80 NPC1 (0.35) ALDH1A1NPC1RAB9AKDM4ENFKB1
SCHEMBL2169969 0.80 CCR1 (0.48) CCR1ALDH1A1TERTNPC1RAB9A
SCHEMBL1914989 0.78 BACE1 (0.53) CCR1ALDH1A1TERTNPC1RAB9A
SCHEMBL13738538 0.78 ALDH1A1 (0.40) CCR1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL8629268 0.78 NPC1 (0.51) ALDH1A1NPC1RAB9AKDM4ENFKB1
SCHEMBL8629269 0.78 NPC1 (0.51) ALDH1A1NPC1RAB9AKDM4ENFKB1
SCHEMBL13738324 0.78 CYP1A2 (0.38) CCR1ALDH1A1MAPT
SCHEMBL10974039 0.76 CYP1A2 (0.49) CCR1ALDH1A1TERTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004065389-A1 PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS MODULATORS OF MULTIDRUG RESISTANCE XENOVA LIMITED (GB) 2004-08-05 WO disclosed